Meyka Pro banner
MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) AI-Powered Stock Analysis

See how MEDIROM Healthcare Technologies Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

MRMNASDAQ
Consumer CyclicalPersonal Products & Services
$0.99
$0.01(1.40%)
U.S. Market opens in 30h 58m

MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) AI-Powered Stock Analysis

See how MEDIROM Healthcare Technologies Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full Disclaimer

MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) Stock Overall Grade

MEDIROM Healthcare Technologies Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

Z

Grade Breakdown by Metric

See how each financial and market factor contributes to MEDIROM Healthcare Technologies Inc.'s overall NASDAQ stock rating.

Forecast

C+

Score

55/100

Financial Growth

C

Score

40/100

Fundamental Growth

C

Score

43/100

Key Ratios

C

Score

45/100

Sector Comparison

A+

Score

95/100

Industry Comparison

C+

Score

50/100

S&P 500 Benchmark

A+

Score

97/100

Analyst Consensus

C+

Score

50/100

MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) AI-Powered Stock Analysis

On the NASDAQ, MRM demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (43/100, C) highlight its stability, while Key Ratios (45/100, C) and Sector Comparison (95/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.

(NASDAQ: MRM) Component Analysis Explained

Understand the key factors behind each MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions